DGS Capital Management LLC Acquires 268 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

DGS Capital Management LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,659 shares of the medical equipment provider’s stock after buying an additional 268 shares during the period. DGS Capital Management LLC’s holdings in Intuitive Surgical were worth $815,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in ISRG. State Street Corp increased its position in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares during the last quarter. FMR LLC increased its stake in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC grew its stake in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. raised its holdings in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after acquiring an additional 24,183 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.1 %

Shares of ISRG stock traded down $0.67 during trading hours on Friday, hitting $544.05. The company’s stock had a trading volume of 135,018 shares, compared to its average volume of 1,435,599. Intuitive Surgical, Inc. has a twelve month low of $320.26 and a twelve month high of $556.23. The stock has a market cap of $193.78 billion, a price-to-earnings ratio of 87.58, a P/E/G ratio of 5.35 and a beta of 1.38. The business has a fifty day moving average of $520.67 and a 200-day moving average of $477.52.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on ISRG. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reiterated an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup raised their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Finally, Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $550.28.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.